Rwandan health authorities recently issued a recall for antifungal tablets produced in Kenya due to safety concerns.
The Rwanda Food and Drug Authority (RFDA) has asked importers to return all batches of Fluconazole 200 mg tablets manufactured by Kenyan company Universal Corporation.
Retailers and healthcare facilities are asked to stop distribution and return affected medications.
The RFDA took this action after informing the Kenyan manufacturer of the discoloration of the tablets. Four bulk batches of pink Fluconazole 200 mg tablets, imported into Rwanda, showed white discoloration shortly after their shelf life began.
The agency pointed out that some of these discolored tablets were already present on the Rwandan market. Health authorities in Rwanda have launched an investigation to determine whether these drugs have had any adverse effects on consumers.
Meanwhile, Kenyan authorities have not yet announced whether the antifungal drug, commonly used to treat fungal infections or yeast infections, will also be recalled from the local market.